HR 8588
116th Congress
House
Health
Congressional oversight
Drug safety, medical device, and laboratory regulation
Economic performance and conditions
Emergency medical services and trauma care
Emergency planning and evacuation
Government studies and investigations
Health care costs and insurance
Health technology, devices, supplies
Intellectual property
Labor market
Manufacturing
Prescription drugs
Improving the American Drug Supply Chain Act of 2020
Introduced: October 13, 2020
Introduced by:
Hudson, Richard
Republican
· North Carolina
See on congress.gov
Everywhere this bill has been
2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Oct 13, 2020
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Foreign Affairs, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Oct 13, 2020
Introduced in House
Plain-English summary
Improving the American Drug Supply Chain Act of 2020
This bill requires the Department of Health and Human Services to enter into an agreement with the National Academies of Sciences, Engineering, and Medicine to (1) study the current and historical production of drugs and key ingredients in the United States and in foreign countries, and (2) formulate recommendations for promoting increased production of drugs and key ingredients in the United States.
What's happening now
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Foreign Affairs, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Committees of jurisdiction
2
Cosponsors
1